JPMorgan Chase & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $882M | Buy |
|
|||||
|
2025
Q1 | $841M | Buy |
|
|||||
|
2024
Q4 | $721M | Sell |
|
|||||
|
2024
Q3 | $1.21B | Sell |
|
|||||
|
2024
Q2 | $1.14B | Buy |
|
|||||
|
2024
Q1 | $744M | Buy |
|
|||||
|
2023
Q4 | $366M | Sell |
|
|||||
|
2023
Q3 | $356M | Sell |
|
|||||
|
2023
Q2 | $423M | Sell |
|
|||||
|
2023
Q1 | $574M | Buy |
|
|||||
|
2022
Q4 | $224M | Buy |
|
|||||
|
2022
Q3 | $201M | Buy |
|
|||||
|
2022
Q2 | $53M | Buy |
|
|||||
|
2022
Q1 | $41.1M | Buy |
|
|||||
|
2021
Q4 | $24.4M | Sell |
|
|||||
|
2021
Q3 | $332M | Sell |
|
|||||
|
2021
Q2 | $616M | Sell |
|
|||||
|
2021
Q1 | $921M | Buy |
|
|||||
|
2020
Q4 | $136M | Sell |
|
|||||
|
2020
Q3 | $1.18B | Sell |
|
|||||
|
2020
Q2 | $1.18B | Buy |
|
|||||
|
2020
Q1 | $763M | Buy |
|
|||||
|
2019
Q4 | $9.66M | Sell |
|
|||||
|
2019
Q3 | $505M | Buy |
|
|||||
|
2019
Q2 | $341M | Sell |
|
|||||
|
2019
Q1 | $431M | Buy |
|
|||||
|
2018
Q4 | $218M | Sell |
|
|||||
|
2018
Q3 | $313M | Buy |
|
|||||
|
2018
Q2 | $156M | Buy |
|
|||||
|
2018
Q1 | $128M | Buy |
|
|||||
|
2017
Q4 | $75.5M | Sell |
|
|||||
|
2017
Q3 | $174M | Sell |
|
|||||
|
2017
Q2 | $234M | Sell |
|
|||||
|
2017
Q1 | $234M | Buy |
|
|||||
|
2016
Q4 | $68.1M | Buy |
|
|||||
|
2016
Q3 | $47.3M | Sell |
|
|||||
|
2016
Q2 | $127M | Sell |
|
|||||
|
2016
Q1 | $161M | Sell |
|
|||||
|
2015
Q4 | $275M | Buy |
|
|||||
|
2015
Q3 | $244M | Sell |
|
|||||
|
2015
Q2 | $359M | Buy |
|
|||||
|
2015
Q1 | $281M | Sell |
|
|||||
|
2014
Q4 | $401M | Sell |
|
|||||
|
2014
Q3 | $351M | Buy |
|
|||||
|
2014
Q2 | $331M | Sell |
|
|||||
|
2014
Q1 | $321M | Buy |
|
|||||
|
2013
Q4 | $293M | Sell |
|
|||||
|
2013
Q3 | $317M | Buy |
|
|||||
|
2013
Q2 | $229M | Buy |
|